AstraZeneca PLC
1323.00
09-五月-25 11:29:56
15 分钟延时
股票
+3.00
+0.23%
今日范围
1306.50 - 1331.50
ISIN
N/A
来源
NASD.OMX SE
-
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
16 5月 2024 03:51:29 条件 NASDAQ US Markets
-
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
08 5月 2024 05:10:43 条件 NASDAQ US Markets
-
AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer
29 4月 2024 02:45:52 条件 NASDAQ US Markets
-
AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer
29 4月 2024 02:45:52 条件 NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 4月 2024 12:52:49 条件 NASDAQ US Markets
-
25 4月 2024 11:30:48 条件 NASDAQ US Markets
-
25 4月 2024 11:15:48 条件 NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 4月 2024 03:16:35 条件 NASDAQ US Markets
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 4月 2024 03:37:17 条件 NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 4月 2024 22:16:14 条件 NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 4月 2024 09:38:12 条件 NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 4月 2024 10:15:53 条件 NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 3月 2024 18:07:03 条件 NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 3月 2024 03:55:20 条件 NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 3月 2024 14:32:29 条件 NASDAQ Stocks
-
AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln
19 3月 2024 03:31:51 条件 NASDAQ US Markets
-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
18 3月 2024 07:40:23 条件 NASDAQ US Markets
-
First Week of AZN May 17th Options Trading
15 3月 2024 12:39:15 条件 NASDAQ Stocks
-
AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline
14 3月 2024 03:46:14 条件 NASDAQ US Markets
-
AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI
13 3月 2024 07:41:44 条件 NASDAQ US Markets